Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05801107
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-06
First Post:
2023-03-24
Brief Title:
Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer NSCLC Patients
Sponsor:
Qilu Pharmaceutical Co Ltd
Organization:
Qilu Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-24
First Submit QC Date:
March 24 2023
Study First Post Date:
2023-04-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-24
Last Update Post Date:
2023-04-06
Last Update Post Date Type:
ACTUAL